Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer

Retrieved on: 2023-09-11 13:57:12

Tags for this article:

Click the tags to see associated articles and topics

Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer. View article details on hiswai:

Excerpt

"Solu's CyTaC platform and focus on unlocking antibody-intractable cell ... a company focused on the development of monoclonal antibodies as ...

Article found on: finance.yahoo.com